News for ResMed Inc. (0KW4.L)

ResMed Inc (RMD), a leader in health technology focused on sleep and respiratory care, released its fifth annual Global Sleep Survey on February 26, 2025. The s

PR NewswireWARSAW, Ind., Feb. 25, 2025 WARSAW, Ind., Feb. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical techn

**media[537346]**

ResMed Inc (RMD) showcases robust revenue growth with a 10% increase in net revenue year-over-year.Significant improvement in gross margin and diluted earnings

Shares of ResMed Inc (RMD) fell 6.80% in mid-day trading on Jan 31. The stock reached an intraday low of $235.00, before recovering slightly to $240.13, dow

ResMed (RMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Matt, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode.

ResMed Inc. (NYSE:RMD) Q2 2025 Earnings Conference Call January 30, 2025 4:30 PM ETCompany ParticipantsMike Ott - Senior Manager, IRMichael Farrell -...

Wall Street is struggling to find risk-on momentum, with major indexes stuck near the flatline at midday as investors assess the latest earnings reports from mega-cap tech stocks and weaker-than-expected U.S.

Shares of ResMed Inc (RMD) surged 3.18% in mid-day trading on Jan 21. The stock reached an intraday high of $247.75, before settling at $247.40, up from its

On January 8, 2025, Brett Sandercock, the Chief Financial Officer of ResMed Inc's subsidiary, sold 1,000 shares of ResMed Inc (RMD). Following this transaction,

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

ResMed Inc (RMD), a leader in digital health technologies and cloud-connected medical devices, has announced that it will release its financial and operational

ResMed Inc (RMD), a leader in digital health technologies and cloud-connected medical devices, announced that its Chairman and CEO, Mick Farrell, along with Chi

On January 2, 2025, Peter Farrell, Director at ResMed Inc (RMD), sold 2,000 shares of the company, according to the SEC Filing. Following this transaction, the

ResMed's global general counsel sells $17,324 in stock

Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Costco Wholesale Corporation (COST) and International Business Machines Corporation (IBM), as well as a micro-cap stock Smith-Midland Corporation (SMID).

Australia stocks higher at close of trade; S&P/ASX 200 up 1.67%

On December 9, 2024, Brett Sandercock, the Chief Financial Officer of ResMed Inc's subsidiary, sold 1,000 shares of ResMed Inc (RMD). Following this transaction